WASHINGTON, D.C. — Liberty Counsel Action (LCA) is calling on the U.S. Food and Drug Administration to revoke its recent approval of a new generic version of the dangerous abortion pill Mifepristone pending an environmental assessment. The FDA quietly approved Evita Solutions LLC’s generic version of Mifepristone in September 2025 despite previously pledging to thoroughly review the drug’s safety.

In an October 10 letter, LCA advised FDA Commissioner Martin Makary that Mifepristone, marketed under the brand name Mifeprex, is both unsafe for women and is an environmental pollutant. The letter cites LCA’s June 2025 special report on Abortion In Our Water, which provides a comprehensive analysis regarding the environmental impact of the abortion pill Mifepristone and human fetal remains entering our water systems. According to the report, the drug not only adversely effects one in 10 women with severe side effects, but the estimated 700,000 chemical abortions that occur every year also contribute to 30-40 tons of hazardous medical waste, including human remains, being flushed into the nation’s water systems.

A key finding from the report shows that there was a complete absence of environmental impact studies before the FDA approved Mifepristone, which the Clean Water Act (CWA) and the National Environmental Policy Act (NEPA) require when federal actions may pollute the environment, like approving a chemical abortion drug. Yet, the abortion industry instructs women to sit on the toilet at home during chemical abortions with full knowledge that fetal remains ranging up to one inch in size will be flushed into the sewers where wastewater treatment plants are not meant to process such human remains or medical waste.

“According to the CWA, Mifepristone and its active metabolites would qualify as pollutants (‘chemical wastes’) that are discharged into wastewater systems and likely to enter our water supply, given conventional wastewater treatment plants do not fully remove these types of contaminants,” reads the letter. “Under the CWA, fetal remains generated from chemical abortions also qualify as ‘pollutants’ that may be discharged into our water systems, threatening environmental safety as said remains lead to clogs, and subsequently, contribute to sewer system overflows.”

LCA stated that these federal laws provide the FDA with the “requisite authority to pause and revoke approval for all generic and brand-name versions of the abortion drug Mifepristone.”

LCA also recommended that the FDA consider following the advice of 22 state attorneys general who advised in July 2025 to reinstate the drug’s previously removed safety regulations and to even withdraw the drug from the market while it completes its promised safety review.

“We respectfully propose the FDA both consider the advice of the aforementioned Attorneys General, and at the least, revoke approval for the Evita Solutions [drug approval] pending a thorough, legally compliant environmental assessment,” LCA’s letter concluded.

Liberty Counsel Action Chairman Mat Staver said, “We are seriously concerned about the FDA’s recent approval of a new generic chemical abortion pill. Not only is the medical complication rate 22 times higher than the rate reported on the FDA-approved drug label, but the amount of human fetal remains being also flushed into our water systems contain active drug components that the water treatment plants are not designed to filter out.  The FDA should remove Mifepristone from the market while a comprehensive and legally compliant environmental assessment is conducted on water contamination caused by at-home chemical abortions.”

For media interviews and speaking engagements, contact: [email protected] or call 407-875-1789.